Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| Revenues | 0.0 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.3 |
| Revenue growth | -100.0% | | | | | | -100.0% | |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.3 |
| Gross profit | 0.0 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross margin | | 100.0% | | | | | | 0.0% |
| Research and development | 5.0 | 5.1 | 5.6 | 5.0 | 1.9 | 0.5 | 0.3 | 0.4 |
| General and administrative | 12.2 | 13.0 | 7.4 | 5.4 | 5.0 | 2.4 | 1.6 | 2.5 |
| EBIT | -17.2 | -17.9 | -13.0 | -10.4 | -7.0 | -2.9 | -1.9 | -2.9 |
| EBIT margin | | -10520.6% | | | | | | -824.4% |
| Pre-tax income | -17.3 | -18.1 | -12.8 | -9.9 | -7.0 | -2.8 | -0.7 | -2.2 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -17.3 | -18.1 | -12.8 | -9.9 | -7.0 | -2.8 | -0.7 | -2.2 |
| Net margin | | -10652.4% | | | | | | -623.5% |
| |
| Diluted EPS | ($0.67) | ($0.76) | ($0.64) | ($0.52) | ($0.47) | ($0.22) | ($0.06) | ($0.22) |
| Shares outstanding (diluted) | 26.0 | 23.7 | 19.9 | 18.9 | 15.0 | 12.8 | 10.8 | 9.9 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|